JP2015523337A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015523337A5 JP2015523337A5 JP2015514142A JP2015514142A JP2015523337A5 JP 2015523337 A5 JP2015523337 A5 JP 2015523337A5 JP 2015514142 A JP2015514142 A JP 2015514142A JP 2015514142 A JP2015514142 A JP 2015514142A JP 2015523337 A5 JP2015523337 A5 JP 2015523337A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- contacted
- solution
- tms
- acetonitrile
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims 23
- 238000000034 method Methods 0.000 claims 19
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims 15
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims 15
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims 12
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims 12
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims 10
- 239000000243 solution Substances 0.000 claims 10
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 claims 8
- HBENZIXOGRCSQN-VQWWACLZSA-N (1S,2S,6R,14R,15R,16R)-5-(cyclopropylmethyl)-16-[(2S)-2-hydroxy-3,3-dimethylpentan-2-yl]-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol Chemical compound N1([C@@H]2CC=3C4=C(C(=CC=3)O)O[C@H]3[C@@]5(OC)CC[C@@]2([C@@]43CC1)C[C@@H]5[C@](C)(O)C(C)(C)CC)CC1CC1 HBENZIXOGRCSQN-VQWWACLZSA-N 0.000 claims 6
- VIMMECPCYZXUCI-MIMFYIINSA-N (4s,6r)-6-[(1e)-4,4-bis(4-fluorophenyl)-3-(1-methyltetrazol-5-yl)buta-1,3-dienyl]-4-hydroxyoxan-2-one Chemical compound CN1N=NN=C1C(\C=C\[C@@H]1OC(=O)C[C@@H](O)C1)=C(C=1C=CC(F)=CC=1)C1=CC=C(F)C=C1 VIMMECPCYZXUCI-MIMFYIINSA-N 0.000 claims 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims 6
- 229940125782 compound 2 Drugs 0.000 claims 6
- 150000001875 compounds Chemical class 0.000 claims 6
- RWWYLEGWBNMMLJ-YSOARWBDSA-N remdesivir Chemical compound NC1=NC=NN2C1=CC=C2[C@]1([C@@H]([C@@H]([C@H](O1)CO[P@](=O)(OC1=CC=CC=C1)N[C@H](C(=O)OCC(CC)CC)C)O)O)C#N RWWYLEGWBNMMLJ-YSOARWBDSA-N 0.000 claims 6
- 229940126214 compound 3 Drugs 0.000 claims 5
- 238000004519 manufacturing process Methods 0.000 claims 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 5
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims 4
- GVOISEJVFFIGQE-YCZSINBZSA-N n-[(1r,2s,5r)-5-[methyl(propan-2-yl)amino]-2-[(3s)-2-oxo-3-[[6-(trifluoromethyl)quinazolin-4-yl]amino]pyrrolidin-1-yl]cyclohexyl]acetamide Chemical compound CC(=O)N[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1N1C(=O)[C@@H](NC=2C3=CC(=CC=C3N=CN=2)C(F)(F)F)CC1 GVOISEJVFFIGQE-YCZSINBZSA-N 0.000 claims 4
- 238000006227 trimethylsilylation reaction Methods 0.000 claims 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 3
- 238000006243 chemical reaction Methods 0.000 claims 3
- VDQQXEISLMTGAB-UHFFFAOYSA-N chloramine T Chemical compound [Na+].CC1=CC=C(S(=O)(=O)[N-]Cl)C=C1 VDQQXEISLMTGAB-UHFFFAOYSA-N 0.000 claims 3
- VSTXCZGEEVFJES-UHFFFAOYSA-N 1-cycloundecyl-1,5-diazacycloundec-5-ene Chemical compound C1CCCCCC(CCCC1)N1CCCCCC=NCCC1 VSTXCZGEEVFJES-UHFFFAOYSA-N 0.000 claims 2
- NOGFHTGYPKWWRX-UHFFFAOYSA-N 2,2,6,6-tetramethyloxan-4-one Chemical compound CC1(C)CC(=O)CC(C)(C)O1 NOGFHTGYPKWWRX-UHFFFAOYSA-N 0.000 claims 2
- WLHCBQAPPJAULW-UHFFFAOYSA-N 4-methylbenzenethiol Chemical compound CC1=CC=C(S)C=C1 WLHCBQAPPJAULW-UHFFFAOYSA-N 0.000 claims 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims 2
- SIPUZPBQZHNSDW-UHFFFAOYSA-N bis(2-methylpropyl)aluminum Chemical group CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 claims 2
- 239000003153 chemical reaction reagent Substances 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 239000007858 starting material Substances 0.000 claims 2
- FTVLMFQEYACZNP-UHFFFAOYSA-N trimethylsilyl trifluoromethanesulfonate Chemical compound C[Si](C)(C)OS(=O)(=O)C(F)(F)F FTVLMFQEYACZNP-UHFFFAOYSA-N 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 2
- FANCTJAFZSYTIS-IQUVVAJASA-N (1r,3s,5z)-5-[(2e)-2-[(1r,3as,7ar)-7a-methyl-1-[(2r)-4-(phenylsulfonimidoyl)butan-2-yl]-2,3,3a,5,6,7-hexahydro-1h-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol Chemical compound C([C@@H](C)[C@@H]1[C@]2(CCCC(/[C@@H]2CC1)=C\C=C\1C([C@@H](O)C[C@H](O)C/1)=C)C)CS(=N)(=O)C1=CC=CC=C1 FANCTJAFZSYTIS-IQUVVAJASA-N 0.000 claims 1
- 239000004367 Lipase Substances 0.000 claims 1
- 102000004882 Lipase Human genes 0.000 claims 1
- 108090001060 Lipase Proteins 0.000 claims 1
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims 1
- 238000002425 crystallisation Methods 0.000 claims 1
- 230000008025 crystallization Effects 0.000 claims 1
- 230000007062 hydrolysis Effects 0.000 claims 1
- 238000006460 hydrolysis reaction Methods 0.000 claims 1
- SNHMUERNLJLMHN-UHFFFAOYSA-N iodobenzene Chemical compound IC1=CC=CC=C1 SNHMUERNLJLMHN-UHFFFAOYSA-N 0.000 claims 1
- 235000019421 lipase Nutrition 0.000 claims 1
- 239000003960 organic solvent Substances 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261650553P | 2012-05-23 | 2012-05-23 | |
| US61/650,553 | 2012-05-23 | ||
| PCT/US2013/042150 WO2013177243A1 (en) | 2012-05-23 | 2013-05-22 | Sulfilimine and sulphoxide methods for producing festinavir |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015523337A JP2015523337A (ja) | 2015-08-13 |
| JP2015523337A5 true JP2015523337A5 (cg-RX-API-DMAC7.html) | 2016-07-07 |
Family
ID=48534517
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015514142A Pending JP2015523337A (ja) | 2012-05-23 | 2013-05-22 | フェスチナビルを製造するためのスルフィリミンおよびスルホキシド方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US9249171B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2852583A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2015523337A (cg-RX-API-DMAC7.html) |
| CN (1) | CN104379571A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2013177243A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20160060252A1 (en) | 2013-04-16 | 2016-03-03 | Bristol-Myers Squibb Company | 5-methyluridine method for producing festinavir |
| WO2014201122A1 (en) | 2013-06-13 | 2014-12-18 | Bristol-Myers Squibb Company | Tert-butyl-sulphoxide method for producing festinavir |
| EP3760208B1 (en) | 2014-06-25 | 2024-05-29 | The General Hospital Corporation | Targeting human satellite ii (hsatii) |
| JP7025064B2 (ja) * | 2018-08-09 | 2022-02-24 | ヤマサ醤油株式会社 | ４’－置換ヌクレオシド誘導体の立体選択的合成法 |
| SG11202107145SA (en) | 2019-01-25 | 2021-08-30 | Univ Brown | Compositions and methods for treating, preventing or reversing age-associated inflammation and disorders |
| AU2023255774A1 (en) * | 2022-04-22 | 2024-12-05 | Rome Therapeutics, Inc. | Didehydro-3'-deoxy-4'-ethynylthymidines and related compounds and their use in treating medical conditions |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0454193A (ja) * | 1990-05-25 | 1992-02-21 | Japan Tobacco Inc | ２’，３’―ジデオキシ―２’，３’―ジデヒドロ―β―リボヌクレオシドの製造方法 |
| JP4980059B2 (ja) | 2003-02-19 | 2012-07-18 | エール ユニヴァーシティ | 抗ウイルスヌクレオシド類似体およびウイルス感染特にｈｉｖ感染の処置方法 |
| ES2617582T3 (es) | 2005-09-26 | 2017-06-19 | Gilead Pharmasset Llc | 4'-Nucleósidos modificados como agentes antivirales |
| WO2009005674A2 (en) | 2007-06-29 | 2009-01-08 | Gilead Sciences, Inc. | Novel hiv reverse transcriptase inhibitors |
| US20090318380A1 (en) | 2007-11-20 | 2009-12-24 | Pharmasset, Inc. | 2',4'-substituted nucleosides as antiviral agents |
| JP5511389B2 (ja) * | 2007-12-27 | 2014-06-04 | オンコリスバイオファーマ株式会社 | ４’−エチニルｄ４Ｔの製造方法 |
| WO2009119785A1 (ja) | 2008-03-28 | 2009-10-01 | 浜理薬品工業株式会社 | エチニルチミジン化合物の精製方法 |
| JP5485140B2 (ja) * | 2008-04-10 | 2014-05-07 | 浜理薬品工業株式会社 | ５−メチルウリジンを出発原料とするエチニルチミジン化合物の製造方法 |
| DE102009034346B4 (de) | 2009-07-23 | 2013-01-24 | Kone Corp. | Antriebssystem für eine Personenförderanlage |
| US9212174B2 (en) | 2010-02-15 | 2015-12-15 | Nissan Chemical Industries, Ltd. | Certain β-dihydrofuran derivatives |
| EP2537851B1 (en) | 2010-02-15 | 2015-06-10 | Nissan Chemical Industries, Ltd. | Process for preparation of b-glycoside compounds |
-
2013
- 2013-05-22 JP JP2015514142A patent/JP2015523337A/ja active Pending
- 2013-05-22 US US14/402,231 patent/US9249171B2/en active Active
- 2013-05-22 EP EP13725545.1A patent/EP2852583A1/en not_active Withdrawn
- 2013-05-22 CN CN201380027023.5A patent/CN104379571A/zh active Pending
- 2013-05-22 WO PCT/US2013/042150 patent/WO2013177243A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015523337A5 (cg-RX-API-DMAC7.html) | ||
| KR102292928B1 (ko) | 축합 헤테로사이클릭 화합물의 제조 방법 | |
| FI3317260T4 (fi) | Asesulfaamikaliumkoostumuksia ja prosesseja niiden tuottamiseksi | |
| JP2015500335A5 (cg-RX-API-DMAC7.html) | ||
| CN101792400B (zh) | 一种阿戈美拉汀的合成方法 | |
| RU2014110400A (ru) | Способ и промежуточные соединения для получения макролактамов | |
| JP2010503694A5 (cg-RX-API-DMAC7.html) | ||
| WO2016058467A1 (zh) | 磷酸泰地唑胺的制备方法 | |
| JP2014528948A5 (cg-RX-API-DMAC7.html) | ||
| JP2010505926A5 (cg-RX-API-DMAC7.html) | ||
| JP2016517886A5 (cg-RX-API-DMAC7.html) | ||
| JP2014510043A5 (cg-RX-API-DMAC7.html) | ||
| JP2009524615A5 (cg-RX-API-DMAC7.html) | ||
| EP2985286B1 (en) | Midbody of ticagrelor and preparation method therefor, and preparation method for ticagrelor | |
| JP2013531058A5 (cg-RX-API-DMAC7.html) | ||
| JP7232618B2 (ja) | アコチアミドの改善された製造方法 | |
| CN103635459A (zh) | 氟硫酸芳环酯类的制造方法 | |
| TWI621609B (zh) | 製備４－鹵烷基－３－巰基－取代之２－羥基苯甲酸衍生物 | |
| JP2015508069A5 (cg-RX-API-DMAC7.html) | ||
| JP2012509267A5 (ja) | （Ｒ）−３−（２，３−ジヒドロキシプロピル）−６−フルオロ−５−（２−フルオロ−４−ヨードフェニルアミノ）−８−メチルピリド［２，３−ｄ］ピリミジン−４，７（３Ｈ，８Ｈ）−ジオンを製造するためのプロセス及びその中間体 | |
| CN103421037B (zh) | 1-乙氧羰基-5-甲基-(3r)-叔丁基二甲硅氧基戊二酸酯的合成工艺 | |
| CN107915696A (zh) | 一种硫代内酯化的方法 | |
| CN106255676A (zh) | α‑溴代苯乙酮化合物的制造方法 | |
| JP2012513391A5 (cg-RX-API-DMAC7.html) | ||
| JP7420550B2 (ja) | ２－ヒドロキシ－２－（パーフルオロアルキル）マロン酸エステル誘導体の製造方法、並びに２－（トリメチルシリルオキシ）－２－（パーフルオロアルキル）マロン酸エステル誘導体及び５－ヒドロキシ－５－（パーフルオロアルキル）ピリミジン－２，４，６（１ｈ，３ｈ，５ｈ）－トリオンとそれらの製造方法 |